Cargando…
Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients
BACKGROUND: Progression of breast cancer involves both genetic and epigenetic factors. Parkin gene has been identified as a tumor suppressor gene in the pathogenesis of various cancers. Nevertheless, the putative role of Parkin in breast cancer remains largely unknown. Therefore, we evaluated the re...
Autores principales: | Wahabi, Khushnuma, Perwez, Ahmad, Kamarudheen, Shabeena, Bhat, Zafar Iqbal, Mehta, Anurag, Rizvi, M. Moshahid A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700819/ https://www.ncbi.nlm.nih.gov/pubmed/31429726 http://dx.doi.org/10.1186/s12885-019-6013-6 |
Ejemplares similares
-
PTEN Genetic and Epigenetic Alterations Define Distinct Subgroups in North Indian Breast Cancer Patients
por: Kazim, Zakia, et al.
Publicado: (2019) -
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008) -
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008) -
Combined kinase inhibition modulates parkin inactivation
por: Rubio de la Torre, Elena, et al.
Publicado: (2009) -
Comparative Study of ZnO-and-TiO(2)-Nanoparticles-Functionalized Polyvinyl Alcohol/Chitosan Bionanocomposites for Multifunctional Biomedical Applications
por: Annu, et al.
Publicado: (2023)